Figure 4.

Expression of LINC00857 target genes in MIBC. Association of LINC00857 target gene expression with response to (A) gemcitabine/cisplatin (Gem/Cis; responders, n = 29; nonresponders, n = 12) and (B) platinum‐based chemotherapy (responders, n = 40; nonresponders n = 20). Kaplan‐Meier analysis showing correlation between recurrence‐free survival and (C) DIAPH3, (D) HLA‐E, (E) LMAN1, (F) PPP2R5E, and (G) UHMK1 expression levels in the MIBC cohort of TCGA. The high and low LINC00857 expression groups were determined based on the 75th and 25th percentiles. The survival curves were analyzed using the log‐rank test